Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]
| Autor: | Mischoulon, D., Hylek, L., Yeung, A.S., Clain, A.J., Baer, L., Cusin, C., Ionescu, D.F., Alpert, J.E., Soskin, D.P., Fava, M. |
|---|---|
| Zdroj: | In Journal of Affective Disorders February 2018 227:198-198 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect